<code id='87E4BD6785'></code><style id='87E4BD6785'></style>
    • <acronym id='87E4BD6785'></acronym>
      <center id='87E4BD6785'><center id='87E4BD6785'><tfoot id='87E4BD6785'></tfoot></center><abbr id='87E4BD6785'><dir id='87E4BD6785'><tfoot id='87E4BD6785'></tfoot><noframes id='87E4BD6785'>

    • <optgroup id='87E4BD6785'><strike id='87E4BD6785'><sup id='87E4BD6785'></sup></strike><code id='87E4BD6785'></code></optgroup>
        1. <b id='87E4BD6785'><label id='87E4BD6785'><select id='87E4BD6785'><dt id='87E4BD6785'><span id='87E4BD6785'></span></dt></select></label></b><u id='87E4BD6785'></u>
          <i id='87E4BD6785'><strike id='87E4BD6785'><tt id='87E4BD6785'><pre id='87E4BD6785'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:3499
          A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat
          PATRICK T. FALLON/AFP via Getty Images

          You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

          Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

          advertisement

          He had a point.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Susan Tousi leaves Illumina to head cancer liquid biopsy startup
          Susan Tousi leaves Illumina to head cancer liquid biopsy startup

          SusanTousiisleavingIlluminatobecomeCEOofcancerliquid-biopsystartupDelfi.NasdaqDelfiDiagnostics,astar

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Flu vaccine offering decent levels of protection this winter, new data show

          JustinSullivan/GettyImagesFluvaccineappearstobeofferingreasonablelevelsofprotectionthiswinter,withpa